This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cigna (CI) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
Cigna (CI) closed at $298.88 in the latest trading session, marking a +0.36% move from the prior day.
Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cigna (CI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Cigna (CI) reachead $305.03 at the closing of the latest trading day, reflecting a +0.98% change compared to its last close.
Top Stock Reports for NVIDIA, Boeing & Sony
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), The Boeing Company (BA) and Sony Group Corporation (SONY).
Can UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results are expected to benefit from an increase in UnitedHealthcare's Medicare & Retirement revenues as well as the number of people it served.
Are Medical Stocks Lagging Cigna Group (CI) This Year?
by Zacks Equity Research
Here is how Cigna (CI) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.
Can UnitedHealth (UNH) Q4 Earnings Navigate Through High Costs?
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results are likely to reflect growth in domestic commercial customers and premium levels.
Cigna (CI) Ascends But Remains Behind Market: Some Facts to Note
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $313.63, moving +0.01% from the previous trading session.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Is Cigna (CI) Nearing a Medicare Advantage Divestment Deal?
by Zacks Equity Research
Cigna's (CI) Medicare Advantage unit's divestment is expected to fetch around $3-$4 billion.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Cigna (CI) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna (CI) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Cigna (CI) concluded the recent trading session at $299.45, signifying a +0.02% move from its prior day's close.
Why You Should Retain Cigna (CI) Stock in Your Portfolio
by Zacks Equity Research
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.
Cigna (CI) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $294.32, marking a +0.77% move from the previous day.
Cigna (CI) Laps the Stock Market: Here's Why
by Zacks Equity Research
The latest trading day saw Cigna (CI) settling at $292.07, representing a +0.54% change from its previous close.
Cigna's (CI) Medicare Advantage Unit Draws Acquisition Interest
by Zacks Equity Research
The final bids for Cigna's (CI) Medicare Advantage unit are expected next week.
The Zacks Analyst Blog Highlights The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment
by Zacks Equity Research
The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment are part of the Zacks top Analyst Blog.
Cigna (CI) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Cigna (CI) closed at $296.71 in the latest trading session, marking a -1.74% move from the prior day.
Top Stock Reports for Home Depot, Advanced Micro Devices & Pfizer
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Advanced Micro Devices, Inc. (AMD) and Pfizer Inc. (PFE).
Strength Seen in Cigna (CI): Can Its 16.7% Jump Turn into More Strength?
by Zacks Equity Research
Cigna (CI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Company News for Dec 12, 2023
by Zacks Equity Research
Companies In The News Are: M, CI, HUM, OXY, HAS.
Cigna (CI) Adds $10B to Buyback Funds, Turns to Bolt-On Buyouts
by Zacks Equity Research
Cigna (CI) expects to maintain average annual adjusted EPS growth within 10-13% in the long term.
Here's Why Cigna (CI) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.